Holdings of Virtus Investment Advisers, LLC
415 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 7.7 % of the equity sleeve
Sector breakdown
- Financials 12.5 %
- Industrials 11.1 %
- Technology 9.4 %
- Health care 8.9 %
- Consumer discretionary 6.1 %
- Materials 3.9 %
- Consumer staples 2.9 %
- Communication 1.7 %
- Utilities 1.2 %
- Real estate 0.8 %
- Energy 0.4 %
- Unattributed 41.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 98.3 %
- KY 0.6 %
- DK 0.3 %
- GB 0.2 %
- DE 0.2 %
- BR 0.2 %
- LU 0.1 %
- KR 0.1 %
- CL 0.1 %
- TR 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 398 | 330.6M $ | 98.30 % |
| 2 | KY | 3 | 1.9M $ | 0.56 % |
| 3 | DK | 1 | 876K $ | 0.26 % |
| 4 | GB | 5 | 831.2K $ | 0.25 % |
| 5 | DE | 1 | 791.4K $ | 0.24 % |
| 6 | BR | 3 | 576.2K $ | 0.17 % |
| 7 | LU | 1 | 191.9K $ | 0.06 % |
| 8 | KR | 1 | 190K $ | 0.06 % |
| 9 | CL | 1 | 185.9K $ | 0.06 % |
| 10 | TR | 1 | 184.9K $ | 0.05 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 401 | Bicycle Therapeutics PLC | 36,601 | 169.8K $ | |
| 402 | Viridian Therapeutics Inc | 8,439 | 165.1K $ | |
| 403 | REGENXBIO Inc | 19,660 | 164.8K $ | |
| 404 | Fulcrum Therapeutics Inc | 20,974 | 160.9K $ | |
| 405 | Lexeo Therapeutics Inc | 27,910 | 160.2K $ | |
| 406 | Altimmune Inc | 51,743 | 159.4K $ | |
| 407 | Invivyd Inc | 117,537 | 152.8K $ | |
| 408 | Sana Biotechnology Inc | 53,052 | 152.8K $ | |
| 409 | Verastem Inc | 28,374 | 150.4K $ | |
| 410 | Keros Therapeutics Inc | 12,676 | 139.9K $ | |
| 411 | ZENAS BIOPHARMA INC | 6,717 | 131.3K $ | |
| 412 | Olema Pharmaceuticals Inc | 8,250 | 123K $ | |
| 413 | Upstream Bio Inc | 10,046 | 90.4K $ | |
| 414 | MEREO BIOPHARMA GROUP PLC | 125,662 | 41.5K $ | |
| 415 | Gossamer Bio Inc | 75,746 | 24.9K $ |